In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors

Overview of attention for article published in Journal of Hematology & Oncology, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 10 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 22 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 17,763 followers.

RT @celltherapynews: A fusogenic nanoparticle-based in situ antigen modification overcame the limitation of target 🎯 antigens paucity and h…

23 Mar 2022

Reply Repost Favourite

A fusogenic nanoparticle-based in situ antigen modification overcame the limitation of target 🎯 antigens paucity and heterogeneity in #SolidTumors, improving the efficacy and broadening the applications of CAR-T cells. https://t.co/XTvlWawR7L https://t.co

23 Mar 2022

Reply Repost Favourite

.@CTCTC_tmc @DrGauravNarula

20 Mar 2022

Reply Repost Favourite

RT @CARTTherapy: In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therap… https…

20 Mar 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.